The article examines the objective, findings, and clinical context described in Doctor convicted in 2 million–pill stimulant scheme.
Approach:
Case: A federal jury in the Western District of Michigan convicted Jonathan Decker of conspiring to distribute controlled substances and six counts of distribution.
Alleged prescribing conduct: The DOJ said Decker prescribed more than 2 million pills of Adderall and other stimulants through Done Global’s online ADHD platform without examining patients, and received more than $1 million.
Broader scheme: The DOJ described a $100 million scheme involving more than 37 million Adderall pills distributed to subscribers nationwide, as well as more than $40 million in social media advertising.
Key Findings:
The DOJ said Decker prescribed stimulants to people with substance use disorders and serious psychiatric conditions, including a patient with schizophrenia whose mother reported worsening psychotic symptoms.
Decker is the 11th defendant convicted in the broader scheme, which also involved six other licensed prescribers, two senior corporate employees, Done Global CEO Ruthia He, and Clinical President David Brody.
He and Brody were sentenced to 72 months and 24 months in prison, respectively, and ordered to forfeit more than $90 million in company revenues.
Decker faces a maximum statutory penalty of 140 years in prison; no sentencing date has been scheduled.
Interpretation:
The DOJ characterized the case as part of a nationwide controlled-substance distribution and health care fraud conspiracy involving Done Global.
Limitations:
The account is based on a DOJ press release; the supplied context does not include Decker’s response or other defense statements.
Decker has been convicted, but his sentence has not yet been determined.
